Clinical Trial Update: Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis

View source ↗

Summary

A completed clinical trial evaluated the relationship between recombinant human erythropoietin dose, serum adiponectin, and all-cause mortality in patients begi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Recombinant human erythropoietin (erythropoietin)

Snippet

Sponsor: Hamamatsu University | Conditions: Hemodialysis | Status: COMPLETED